Introduction
Allogeneic haematopoietic stem cell transplantation (HSCT) is curative therapy for many malignant and nonmalignant conditions, including leukaemia, lymphoma, bone marrow failure syndromes, haemoglobinopathies, immunodeficiencies and inborn errors of metabolism.
Historically, bone marrow had been used as the sole source of haematopoietic stem cells (HSCs) for transplantation. However, bone marrow transplantation is only an option if there is a suitable HLA-matched donor. Only 25-30% of patients have a family donor and the remainder relied on unrelated bone marrow donor registries. Unfortunately, even with the number of bone marrow volunteers on international registries exceeding 10 million, 1 many patients, particularly those from indigenous and ethnic minority communities, will not find a suitable donor. The reason for this is twofold. First, in recent years it has become clear that HLA variation between individuals is greater than anticipated when defined at the level of DNA than when defined by less precise serological typing, meaning that it is harder to identify a fully matched donor. Second, the probability of finding a donor is higher within the same ethnic group as that of the recipient. Thus, patients from an ethnic group that is poorly represented on donor registries are much less likely to find suitable donors. As most volunteers on the US, European and Australian registries are of North Caucasian descent, there is a powerful ethnic bias that makes transplantation a much less likely option for many patients from non-Caucasian (ethnic) and indigenous populations. This is a particular issue in Australia, which has both a large indigenous population as well as many who have immigrated from Asia, Middle East and South America, or who are of mixed ethnic backgrounds.
In recent years, there has been increasing use of umbilical cord blood (UCB) as an alternative source of HSCs for patients who do not otherwise have an HLA-matched donor. It was hoped that the development of UCB banks would help increase the number of HSC donors particularly from ethnic minority groups, and thus the number of individuals for whom transplant was an option; as well as assist in addressing the ethnic underrepresentation evident in bone marrow donor registries worldwide.
Since first proposed, the use of UCB as a source of HSCs for transplantation has expanded rapidly, with an increasing number of transplant centres performing UCB transplants. To date, approximately 6000 UCB transplants have been performed worldwide, 2 with 120 performed in Australia by 2005. 3 UCB transplants were initially restricted to children and adults weighing less than 40 kg 4, 5 to achieve low acceptable rates of graft failure and transplant-related mortality. However, improved outcomes with single UCB unit transplants in adults 6, 7 and the use of 'double cord' blood transplants, where two UCB units are transplanted, 8 have led to the increasing use of UCB in adults.
In This study investigates whether the Auscord banks have fulfilled their original clinical and social task to provide significant health benefits for Australian patients (in terms of its opportunity cost) and to provide increased access to HSCT-especially for those of indigenous and ethnic descent. Have the UCB banks increased equity in transplantation, or simply contributed to existing inequities? In order to do this, this paper analyses the ethnic diversity of the SCBB, comparing this diversity to that of the Australian Bone Marrow Donor Registry (ABMDR). It also looks at the ethnic diversity of those patients who, after requesting an HSCT in the 2-year period between 2003 and 2005, managed to find a suitably matched bone marrow or UCB donor. On the basis of these findings, this paper considers the implications of UCB banking in terms of health benefits to Australian patients.
Materials and methods

Data
Electronic data on ethnicity were provided by the SCBB for CBUs collected from the commencement of banking at the SCBB from 1995 to mid-2005. At this time, the SCBB had banked 9589 UCB units, and 18 851 UCB units had been banked from Sydney, Melbourne and Queensland combined. As of June 2005, the Auscord banks had validated and made available for searching by transplant centres 12 817 CBUs (due to regulation by the Therapeutic Goods Association). The SCBB initially collected from one maternity unit in the eastern suburbs of Sydney where the predominant ethnic minority group is Jewish; extended to the inner western suburbs in 1998, where Pacific Islander, Asian and Southern European populations are the predominant ethnic minority groups; and then to the southern suburbs in 2001, where Asian and Middle Eastern populations are the predominant ethnic minority groups. During the period under study, mothers were recruited by providing an information brochure through the antenatal clinics and obstetrician's private rooms. No ethnic group was specifically targeted. The SCBB collected from donors who had comprehension of English or for whom an interpreter was available. All donors are de-identified to ensure confidentiality.
Definition of ethnicity
Data on UCB and bone marrow donor/patient ethnicity relied upon self-reported ethnicity in response to a direct questionnaire. The SCBB collects information about both the country of birth and the ethnicity of both parents. The ABMDR asks donors/patients for their and their ancestors' ethnic origin, and patients are asked for their race and geographic ethnicity. Assumptions were made in the course of data analysis. First, that those who classified themselves as 'European' intended to be categorized as South European rather than North Caucasian; and second, where donors or patients stated their ethnicity as 'Australian' they were classified as 'unknown' since the term 'Australian' provides no useful information in regard to ethnicity (n ¼ 10 for patients searching the ABMDR).
Ethnic composition of the SCBB Data regarding the ethnicity of donors to the SCBB were categorized by year and was available for 1995-2005. The ethnicities provided by the donors were categorized into broader ethnic groups that included North Caucasian, South European, Asian, African, Middle Eastern, Indian sub-continent, Hispanic, Pacific Islander, Australian aboriginal, Jewish and mixed ethnicity. During the categorization process, if more than one ethnicity was reported, both/ all of the ethnicities were maintained for analysis, and the donor was categorized as having 'mixed' ethnic descent. Data regarding the ethnicity of patient requests initiated at the ABMDR All searches initiated for patients via the ABMDR between 1 July 2003 and 30 June 2005 were analysed to ascertain the outcome of their search. Data were available in the ABMDR database regarding patients who had received a transplant (bone marrow or UCB), or who had cancelled their search. For the remainder of the patients still actively searching for a donor, the information required analysis of the patient files to determine their search progress.
Ethnic composition of the ABMDR
A total of 778 patients initiated a search between the specified dates. Two patients were excluded: one patient was not an Australian citizen, and data on a second patient could not be found. This work was commissioned by the National Management Board of the ABMDR to provide a basis of future planning.
Statistics
Associations between ethnicity, and success and source of finding a match were assessed with w 2 tests, conducted using the SAS System for Windows, version 9.1. Fisher's exact test was used for tables with a number of cells with low frequencies.
Results
Ethnic diversity of UCB donors
Data regarding the ethnicity of donors were categorized by year through 1995-2005 and on an overall basis. Apart from the first 2 years when numbers were small, the past decade has seen a substantial increase in the absolute numbers of UCB donors; the North Caucasian, South European and Asian populations, as well as the population of mixed ethnic ancestry, showed the largest increases in donor numbers (Table 1) .
Proportionally, since 2000, the intake of North Caucasian donors to the SCBB has remained steady (range 55-58% of total donations). In 1999 and 2000, there was an increase in donations from the Asian population with a proportionate decrease from the Northern Caucasian population; and there was a steady increase in donations from the South European population from this point onwards. There was little change in donation rates from other ethnic groups from this time.
Comparison of ethnic diversity of the SCBB and ABMDR In comparing the two separate databases (SCBB and ABMDR), some additional assumptions were required as outlined in Table 2 donor identified (Table 3 ) (for bone marrow donors this was a 6/6 HLA-match and rarely a 5/6 match, and for UCB donors this was a 4/6, 5/6 or 6/6 HLA-match). This encompassed 55% of North Caucasian patients and 65% of the mixed ethnic population. Lower success rates were seen in the Asian (38%), aboriginal Australian (33%) and Indian (0%) populations (there was evidence of an association between ethnicity and success rate (Fisher's exact test, P ¼ 0.03). Table 4 shows the ethnic breakdown of patients who, after identifying a suitable donor, received either a bone marrow or UCB transplant. Of the 385 patients who identified a Forty-three per cent of bone marrow donors and 36% of UCB donations were sourced internationally for transplant. Of the transplants performed on ethnic minority group patients, 67.5% of bone marrow donors were sourced internationally compared with 45% of UCB donations.
Donor location
Source of donation for those patients who received a transplant
n (%) n (%) n (%) n (%)
Discussion
Despite a large number of volunteer bone marrow donors being registered on the national and international databases, many Australian patients in need of a transplant do not find a suitably matched donor either locally or overseas. Unfortunately, studies show that doubling the number of donors on the ABMDR will only increase the chance of finding a donor by 5%. 12 Primarily, this is because ethnic minority patients are underrepresented and the probability of finding a donor directly correlates with the ethnicity of the recipient. UCB banks were established to meet the gap between patients needing a transplant and finding a suitable unrelated bone marrow donor, either nationally through the ABMDR or the international bone marrow donor registries. It was anticipated that recruitment of ethnic minority groups to UCB banks, as well as the fact that a UCB donor does not need to be completely matched for a successful transplant, would help increase the number of individuals for whom transplant was an option.
The past decade has seen a substantial increase in the total number of UCB donors to the SCBB (and the Auscord network of UCB banks; data not shown). Although the proportion of ethnic minority group donors has not increased over this time, the ethnic mix of donors has remained generally broad in source and is comparative to the Australian population. The trends seen in donation rates could have occurred for a number of reasons, the most likely being the addition of collection centres to new sites of differing ethnic diversity over the course of the decade, a changing pattern of donor choice/motivation to donate and a change in awareness to UCB donation. Further, the consistently low proportion of donation rates from the Australian aboriginal, Hispanic, African and Indian populations could be attributed to the small proportion of these groups within the metropolitan areas of Sydney.
The SCBB is more ethnically diverse than that of the ABMDR. This reflects the fact that worldwide it appears that Northern Caucasian individuals more readily donate bone marrow. Two points must be noted here. First, the ABMDR data include 3512 Thai donors and 7504 NZ donors (Maori/Polynesian), accounting for the higher representation seen in these ethnic groups, especially the Pacific Islander group. Second, while the proportion of donations to the ABMDR from individuals of mixed ethnicity is 20 times lower than the proportion of donations to the UCB banks, this result may not be as significant since before 1999 the ABMDR database did not allow input of a mixed ethnicity.
Unfortunately, this may still not be sufficient to substantially increase the likelihood of finding a donor for some ethnic minority groups. This is because the number of UCB donations alone does not determine the likelihood of finding a suitably match donor, the heterogeneity of a population also plays a role. For highly heterogeneous populations, such as the Indian and Australian aboriginal populations, even with substantial increases in UCB donation rates, there will only be slight increases in the likelihood of finding a suitably matched donor, the converse is true for homogeneous populations; suggesting that it will be much more difficult to achieve true equity in opportunity for transplantation for heterogeneous populations in Australia.
Sourcing a donor internationally helps with these equity concerns: it acts as a back up to national searches and increases the chance of finding a suitably matched donor by 45% (42% for North Caucasians and much higher for other ethnic minority groups). It also increases the chance of having a transplant by 41.6% (43% for bone marrow transplants and 36% for UCB transplants; these figures are substantially higher for ethnic minority groups, especially those sourcing a bone marrow donor). Sourcing donors internationally is costly. For example, prices for UCB sourced from an international donor range from US$20 000 to $30 000 (plus approximately US$3000 for shipping). Collection and storage of an Australian UCB unit costs $1800. However, ongoing storage costs are calculated as the total funding invested into Australian UCB banks divided by the total number of UCB units sourced. Therefore, the overall cost of sourcing an Australian UCB unit is indirectly correlated to the number of Australian UCB units used, with the cost benefits of UCB banks becoming evident as more units are sourced for transplant. Economically, therefore, it makes sense to further increase UCB bank ethnic diversity. Since at present only 1 in 10 donated Australian UCB units is unique in the world (at the broad typing level) and this is most likely due to the predominance of North Caucasian donors, this can be attained by active recruitment of donors from ethnic minority populations. Increasing UCB bank ethnic diversity would also have beneficial effects on health factors, such as increasing the availability and speed of finding a UCB unit for a patient.
There is little doubt that this strategy requires continued investment in public UCB banks, attention to geographical and sociodemographic factors that may influence UCB donation and continuing education and awareness programs for those ethnic minority groups currently underrepresented in public banks. It is noteworthy that the ABMDR has already implemented UCB education programs in the Northern Territory for Aboriginal Australian communities and the SCBB is about to commence collection of UCB in Darwin, and the Queensland UCB banks are working to increase the number of donations from the Pacific Islander populations. The establishment of further collection centres in regions of high ethnic diversity could also help increase the heterogeneity of the UCB banks, as well as provide better equity of access to mothers.
At present, UCB collection site location has been determined more by the interest and acceptance of hospital staff at a specific site, rather than the need to specifically target ethnic minority groups. Simply locating UCB collection centres within target populations will not, in itself, however, resolve the problems involved in recruiting donors from underrepresented ethnic populations. Indeed, given the enormity of the challenge, the global nature of the donor registry system and the fact that approximately 5000 UCB units need to be collected before there is a significant increase in the probability that an individual from an underrepresented ethnic minority will find a suitably matched donor (M Vowels, personal communication), it may be argued that it would be more valuable and costeffective to selectively target only a few of the groups that are currently underrepresented on donor registries, such as the Australian indigenous population, those of mixed ethnic descent, and/or those populations who originate in countries that do not have large UCB inventories, as it is those populations who will have more difficulties finding a suitably matched donor.
This study has a number of limitations. First, this study was conducted during the development phase of UCB banks and given that the 'searchable' UCB pool size when this analysis occurred was 12 817 units in June 2005 for the development phase as opposed to the 22 239 cord blood units (CBUs) banked and 17 239 CBUs searchable as of the end of 2006. This study can thus identify trends in the data over a decade, but cannot really provide an explanation or causation. Second, as this study was conducted during the early days of UCB transplantation in Australia when data were still accruing about the efficacy and safety of UCB transplants, it is likely that physician choice, rather than the ethnicity of the patient, would have determined whether a bone marrow/peripheral blood or UCB donor was selected, thus misrepresenting the ethnic representation of UCB banks. Indeed, some physicians-those less aware of the benefits of UCB transplantation-may have searched the ABMDR solely for a suitably matched bone marrow donor, disregarding the option of a UCB transplant (especially for adult patients). Third, as has been already noted, discordance in the categories of ethnicity used by the SCBB, the ABMDR and the Australian Bureau of Statistics limit the conclusions that can be drawn about the degree to which UCB banks represent the ethnic breakdown of the Australian population. Fourth, although Table 4 compares the number of bone marrow and UCB transplants that have been performed in Australia, it would also be interesting to compare those patients who found a suitable donor (and did not necessarily proceed to transplant) in terms of stem cell source. Unfortunately these data are not available. Finally, we are aware that in addition to ethnicity there are a series of factors that determine the success of a transplant, including disease type, the number of HLA matches and cell count.
This study is the first empiric analysis of the public UCB banking system in Australia and, while we do note the limitations, we believe that our analysis has provided a useful insight into the current UCB collection strategies in Australia.
